Company / Current Assets
Korro Bio, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$82.4M
FY2025
5-year range
$82.4M / $225.1M
FY2021-FY2025
Trend
-37.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 6 years, ranging from $82M in FY2025 to $225M in FY2020.
Based on SEC 10-K filings.
$82M in FY2025 with a 5-year CAGR of -18.2%.
Declined from $87M to $82M over the past 3 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -2.0%
- 5-Year CAGR
- -18.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -18.2%, indicating a declining trend.
- In FY2025, current assets decreased 37.4% year-over-year.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $82.4M | -37.4% |
| FY2024 | $131.5M | +50.3% |
| FY2022 | $87.5M | -35.1% |
| FY2021 | $134.7M | -40.1% |
| FY2020 | $225.1M | +1.7% |
| FY2019 | $221.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026